Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with ...

In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...

EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA ...

Combining baricitinib with narrowband UVB phototherapy led to significant repigmentation and enhanced quality of life in ...

Vitiligo is believed to be an autoimmune condition where the body attacks its own healthy melanin-producing skin cells by mistake. It may be hereditary or triggered by a particular event like ...

Medically reviewed by Jamin Brahmbhatt, MDVitiligo on the penis occurs when patches of skin change color, just as they can on ...

Incyte's Opzelura cream has become the first medical treatment approved to re-pigment the skin of people with vitiligo in the US, adding to its current use in atopic dermatitis.

If you’re under age 12, we don’t have any drug that is specifically indicated,” Dr. Lawrence F. Eichenfield said.

Regenerative medicine focuses on repairing damaged skin and bringing back melanocytes, the cells that give skin its color.

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

Patients with vitiligo or alopecia areata had lower BMI and lipid dysregulation, but this relationship was not observed in patients with psoriasis.

Healio compiled the most-read vitiligo articles of 2024. Image: Adobe Stock. Other top stories include Healio’s Beneath the Surface video series, clinical data on novel treatment options and ...